Integra LifeSciences prices $450 million of 9.5% senior secured notes due 2033
Integra LifeSciences Holdings announced on Oct. 9, 2026 that it priced a $450 million senior secured note offering with a 9.5% coupon, maturing in 2033. The transaction is slated to close on or about Oct. 19, 2026, subject to customary conditions. Net proceeds, together with borrowings under new credit facilities, will be used to refinance existing credit facilities, pay related fees and support additional borrowing capacity.
Why it matters
The company indicated that the new notes will raise its financing costs, which could affect cash‑flow dynamics. The refinancing replaces older debt with higher‑interest obligations, altering the capital structure and potentially impacting credit metrics for investors.
Key facts
- 1The aggregate principal amount of the notes is $450,000,000. quiverquant.com
- 2The notes carry a 9.500% coupon rate. quiverquant.com
- 3Maturity is set for 2033. quiverquant.com
- 4Closing is expected on or about October 19, 2026. quiverquant.com
- 5Proceeds will refinance existing credit facilities and pay fees and expenses. tradingview.com
- 6Proceeds, together with new credit facility borrowings, will support additional liquidity needs. gurufocus.com
Summary written by AlphAI AI Desk from 10 of 10 sources. Not investment advice. Figures are as stated by the linked sources.